Steroids May Improve Outcomes For Community-Acquired Pneumonia

Reed A.C. Siemieniuk, MD Department of Clinical Epidemiology & Biostatistics Ontario CanadaMedicalResearch.com Interview with:
Reed A.C. Siemieniuk, MD
Department of Clinical Epidemiology & Biostatistics
Ontario Canada

Medical Research: What is the background for this study? What are the main findings?

Dr. Siemieniuk: Local and cytokine-mediated systematic inflammatory responses help clear bacterial pathogens in community-acquired pneumonia (CAP), but often they can also cause harm. Pneumonia is the most common cause of the acute respiratory distress syndrome (ARDS), an often fatal inflammatory complication. Two randomized trials were published earlier this year, each of which suggested the possibility of  benefit from adjunctive corticosteroid therapy. We decided to perform a systematic review and meta-analysis, taking all available data into consideration.

Corticosteroids may be effective for reducing the incidence of ARDS by 6%, the need for mechanical ventilation by 5%, and mortality by 3% (all moderate confidence). They also reduce time to clinical stability and time to discharge by approximately 1 day (high confidence).

For an interactive summary of findings table that shows the study’s findings, please see: http://isof2.epistemonikos.org/#/finding/550bc6acf30d0c43083e63a0.

Medical Research: What should clinicians and patients take away from your report?

Dr. Siemieniuk: Corticosteroids might improve outcomes for patients hospitalized with community-acquired pneumonia. The argument for using corticosteroids in pneumonia is strongest among those with severe pneumonia. Our recommendations can be found at: http://www.magicapp.org/app#/guideline/516.

Medical Research: What recommendations do you have for future research as a result of this study?

Dr. Siemieniuk: Future randomized trials would increase the certainty in evidence for corticosteroids in community-acquired pneumonia. In the mean time, it is worth weighing the risks and benefits for the any patient hospitalized withcommunity-acquired pneumonia.

Citation:

Siemieniuk RA, Meade MO, Alonso-Coello P, Briel M, Evaniew N, Prasad M, et al. Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis. Ann Intern Med. [Epub ahead of print 11 August 2015] doi:10.7326/M15-0715

MedicalResearch.com is not a forum for the exchange of personal medical information, advice or the promotion of self-destructive behavior (e.g., eating disorders, suicide). While you may freely discuss your troubles, you should not look to the Website for information or advice on such topics. Instead, we recommend that you talk in person with a trusted medical professional.

The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.

 

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.